COLL vs WMT · P/E 17, rev $181.9M vs P/E 42, rev $713.16B
Collegium Pharmaceutical Inc (COLL) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the COLL and WMT stock pages for the full models.
Not investment advice.